Dr Timothy Low ,Pbm,Author,Ceo,Board Director Email and Phone Number
Singapore
Dr Timothy Low ,Pbm,Author,Ceo,Board Director's Location
Singapore, Singapore
Dr Timothy Low ,Pbm,Author,Ceo,Board Director's Contact Details
Dr Timothy Low ,Pbm,Author,Ceo,Board Director work email
- Valid
- Valid
Dr Timothy Low ,Pbm,Author,Ceo,Board Director personal email
n/a
About Dr Timothy Low ,Pbm,Author,Ceo,Board Director
Providing the vision, leadership and direction needed to achieve financial, strategic, medical and clinical excellence in the Bio-pharmaceutical and medical device industries, as well as the hospital / healthcare organizations.Medical Affairs and Clinical Affairs Leader in Pharmaceuticals and Medical Device Regional Medical Director, Asia-pacific.Contract Research Organisation (CRO) pioneer in Asia, providing outsourced international management of clinical trials for R&D and post-marketing surveillance.Hospital Administrator, Chief Executive Officer of Parkway Pantai's flagship Gleneagles Hospital , spearheading the award-winning hospital to a 6-Star service hospital with JCI accreditation.Led a new private tertiary healthcare institute, Farrer Park Hospital , as Chief Executive Officer and Board Director, with revenues >USD100 Million and EBITDA >25% .Headed the global healthcare investment in VC/PE in Singapore's State investment firm, Pavilion Capital/Temasek Holdings, with MOIC >3xOver 30 years medical experience, displaying the vision and values necessary to lead transformation which maximise people, asset value and long-term growth, delivering exceptional results across service leadership to customers and healthcare professionals. With a demonstrated history of achieving success through new operational start-ups and operational turnarounds, earned a reputation as someone who is a high end achiever and innovative leader in Asia-pacific.Awarded the “50 Most Talented Healthcare Leaders of Asia” in 2016. Awarded “Best CEO of the Year” at the Asia Healthcare Excellence Award in 2017.In 2018, he was conferred the "Icons of Healthcare"- Leading Healthcare Management Professional of the Year and Rare Disease Champion Provider of the Year in Asia Pacific. He was also recognized as the "Most Media Savvy Personality" by GlobalHealth Asia Pacific in 2019. In 2023, he was awarded the National Awards - Public Service Medal (Covid-19), PBM, and Covid-19 Resilience Medal (CRM) & Top Motivational Speaking Voice by LinkedIn in 2024. Specialties: Strategic and business planning, Medical Advisory strategies, Pharmacovigilance and safetyGlobal clinical operations, Clinical trial management, Clinical Affairs, Medical Affairs, Operational start-ups, Budget and cost control, Organising Advisory Boards, Service Leadership, Scientific specialist, Product registration support, Hospital Administration, Staff management, Infrastructure development.
Dr Timothy Low ,Pbm,Author,Ceo,Board Director's Current Company Details
Dr Timothy Low ,Pbm,Author,Ceo,Board Director Work Experience Details
-
Ceo And Board DirectorFarrer Park HospitalSingapore
-
Executive Vp, Healthcare Services, Board Advisor To Quikbot CorporateQuikbot Technologies Jan 2024 - PresentSingapore, SgOur mission is to revolutionize Last-Mile delivery in Smart Cities with our Autonomous Final-Mile Delivery PaaS. -
Book Author - Dr Timothy Low 刘森旺The Triangulation Of Success Nov 2021 - PresentDrawing from his decades of leadership experience as CEO for large organizations, Dr. Timothy dives into the reasons why some companies can achieve one success after another while others fall into obscurity. In the Triangulation of Success, he explained that it’s all about how the service of the leader impacts the organization, flowing from the top-level management to the staff member on the ground.A consistent theme throughout the book is the idea that people are the greatest asset to a company. As a leader in your career, the way you treat people means all the difference between imminent failure and great success. As we face the predicament of geopolitical crises and the unprecedented threat of a global virus today, the need to be caring and empathetic to the needs of the people around us has never been greater.
-
Healthcare Investment ConsultantPavilion Capital International ( A Member Of Temasek Holdings ) Jan 2022 - PresentConducted thorough financial analysis of healthcare-related investments, evaluating risks and opportunities to guide decision-making processes. Utilized financial models, projections, and valuation methodologies to assess potential returns. I also researched and analyzed healthcare industry trends, regulatory changes, and market dynamics to identify investment prospects. Stayed informed about healthcare policies, reimbursement structures, and emerging technologies impacting the sector.I have also led due diligence processes for healthcare investment opportunities, assessing the viability of projects and potential impacts on financial performance. Assessed target companies, evaluating their financial health and competitive positioning. Prepared comprehensive investment reports, documenting key findings, analyses, and recommendations for internal and external stakeholders. Ensured accuracy and transparency in all reporting activities.Accomplishments• Participated and completed >30 Healthcare Deals, MOIC 3.2 X, IRR >20%, and invested USD 500 Million
-
Head Of Healthcare InvestmentPavilion Capital International ( A Member Of Temasek Holdings ) Jun 2019 - Dec 2021Pavilion Capital is wholly owned and funded by Temasek(Singapore State Investment) , an investment company based in Singapore. Our focus is on funds and direct co-investments in companies that ride on the growth and transformation of the North Asia and Southeast Asia economies. We also invest in US, Europe and Isreal.We pursue investments across different sectors, particularly in innovative technology and healthcare. We embrace sustainability and apply ESG considerations in our investment activities.As at Dec 2020, Pavilion’s total AUM is over S$14b across > 100 GP relationships; > 200 funds.Participated and completed >30 Healthcare Deals , MOIC 3.2 X , IRR >20% , invested USD 500 Mil.
-
MemberThe Bayhelix Group Feb 2020 - PresentSan Francisco, Ca, UsThe BayHelix Group is a non-profit professional organization of business leaders with a mission to shape the growth of the life sciences and healthcare industry. Founded in 2001 in the San Francisco Bay Area, BayHelix has grown to over 800 members globally with a strong presence in China and the US. BayHelix aspires to foster and create business opportunities, supply and nurture leaders for the community, and network and share information and experience among its members. The diverse membership base covers many of the world’s top pharmaceutical and biopharmaceutical companies, leading professional services and investment firms, as well as start-up biotech companies in China and the US. BayHelix membership is by-invitation only. Over two thirds of members are C-level executives. The majority of them are cross trained in science and business as well as bilingual in Chinese and English. BayHelix has become an influential organization that connects emerging biopharmaceutical companies in China to their counterparts around the world. -
Member Of The Board Of AdvisorsAum Biosciences Aug 2020 - PresentSingapore, Singapore, SgAUM Biosciences (AUM) is an oncology-focused Asian biotechnology company committed to developing affordable cancer therapies. AUM is dedicated to revolutionizing the existing inefficient drug development paradigm by harnessing the power of precision medicine and digitalisation. AUM focuses on early stage development of innovative treatment of cancers prevalent in Asia with the potential to address global markets. Led by a highly experienced management team with over 100 years of combined oncology drug development experience, AUM is disrupting the drug development paradigm by implementing a holistic approach to developing drugs. Headquartered in Singapore, AUM is strategically positioned to work, partner and collaborate with leading research institutes, pharmaceutical companies and clinicians globally. AUM is the recipient of Frost & Sullivan’s 2019 Asia-Pacific Biotech Entrepreneurial Company of the Year. The company holds exclusive worldwide rights in all disease indications for 2 first-in-class composition of matter technologies. 1) MNK Inhibition and 2) Multi-Kinase Inhibition (PIM/PI3K/mTOR). -
Advisory BoardHealth Fx Mar 2018 - PresentSingapore, Singapore, SgHealth FX is revolutionising the Healthcare industry by combining the power of A.I./Machine Learning with Blockchain to optimise patient-specialist matching, enable seamless insurance pre-approvals/rebates and payments, and provide consumers and healthcare providers with validated reviews. -
Ceo & Board DirectorFarrer Park Hospital Nov 2021 - Dec 2023Singapore, SgI am a healthcare executive with a proven track record in steering organizations toward operational excellence and sustainable growth. I am also dedicated to fostering innovation, optimizing patient outcomes, and driving financial performance. Aim to lead a visionary healthcare organization that prioritizes patient-centric care, embraces technological advancements, and achieves unparalleled success in a rapidly evolving healthcare landscape.I also spearhead strategic initiatives to align organizational goals with evolving healthcare trends. Visionary leadership in navigating complex healthcare landscapes for sustained growth. I have expertise in steering boards through governance challenges and ensuring regulatory compliance. Guiding organizations in adhering to healthcare policies, ethical standards, and legal frameworks.
-
Board Of DirectorsFarrer Park Hospital Aug 2017 - Dec 2023Singapore, SgProvide visionary leadership, setting the strategic direction for the hospital in alignment with industry trends and regulatory requirements. Drive organizational growth through the development and execution of comprehensive business strategies. I also oversee financial performance, ensuring sustainable revenue streams and cost-effective operations. Implement budgetary controls, optimize resource allocation, and monitor financial health to achieve profitability targets.My role also entails streamlining hospital operations for efficiency, implementing process improvements and quality assurance measures. Oversee the execution of policies and procedures to ensure compliance with healthcare regulations.Accomplishments: • Bagged the 50 Most Talented Healthcare Leaders of Asia Award at the Chief Marketing Officer (CMO) Asia Event in Aug 2016.• Authored Book titled “The Triangulation of Success” in Nov 2021
-
Chief Executive OfficerFarrer Park Hospital Sep 2015 - Sep 2017Singapore, SgFarrer Park Hospital is a new private tertiary healthcare institute establishment. Designed by healthcare practitioners, the hospital aims to deliver a patient-centric healthcare experience in Singapore and Asia. The hospital is part of Connexion – Asia’s first integrated lifestyle hub for healthcare and wellness that also houses a specialist medical centre and a five-star hotel and spa. Farrer Park Hospital is part of Singapore-based The Farrer Park Company, formed by a group of eminent private medical and hospitality specialists with selected foreign investors. The hospital’s care philosophy extends beyond healing and the management of disease, to engaging patients as partners in the pursuit of good health. Patients are treated by an experienced team of medical and health specialists in an environment meticulously designed to maximise comfort and efficiency while promoting well-being, rest and recovery. The hospital’s services and facilities include operation suites, a diagnostic imaging centre, a radiotherapy suite, nuclear medicine suite and laboratory. Patients are accommodated in four floors of inpatient suites with a range of room sizes and privacy levels to match patient’s preferences and comfort levels.Dr Timothy Low has been awarded the “50 Most Talented Healthcare Leaders of Asia” award at the Chief Marketing Officer (CMO) Asia event held at Pan Pacific Hotel on 5 August 2016.
-
Board MemberPan-Asian Clinical Research Association (Pacra) Jan 2010 - Dec 2020Singapore, Sg -
Chief Executive OfficerSheerhealthcare International Jan 2010 - Dec 2020
-
Regional Medical Head, Apac + Japan (Shire - A Takeda Company )Takeda Oct 2017 - May 2019Tokyo, Jp• Rendered strategic alignment with Global and Regional Medical Affairs and execution of the medical affairs activities in the region, including Medical Affairs strategy, data dissemination, evidence generation, medical leadership, medical knowledge/insight management, KOL engagement and management and medical community interactions• Focus on the adoption of global MA processes, including but not limited to HR, Finance, Ethics and Compliance, and contribute to process improvement initiativesProvided strategic alignment with Global and Regional Medical Affairs and execution of the full scope of medical affairs activities in the region, including Medical Affairs strategy, data dissemination, data generation, medical leadership, medical knowledge/insight management, and medical community. In coordination with International MA Head, works with Country Medical Leads (CMLs), their teams and other MA colleagues to ensure appropriate alignment of resources and activities with Global Strategies across TAs in the region.Ensures adoption of global MA processes, including but not limited to HR, Finance, Ethics and Compliance and contributes to process improvement initiatives.Ensures medical guidance and cross-functional collaboration in the areas of new product launches and in-line products.Plans, directs and oversees the medical affairs operations in the region, encourages the optimum performance and provides development opportunities for all medical affairs employees in the region.Leads the Regional Medical Affairs Leadership Team and serves as a member of the International Medical Affairs Leadership Team (IMALT). In addition, represents MA on the regional cross-functional leadership team.Awarded the 'Rare Disease Champion Provider of the Year in Asia Pacific 2018'. -
Vice President , Medical Affairs , Asia PacificCovidien (Medtronic Minimally Invasive Therapies Group) Dec 2010 - 2015Fridley, Minnesota, Us• Rolled out the Global Medical Affairs strategies and tactics for Surgical Devices. Rendered operational support and strategic direction to Clinical Operations, Procedural And Clinical Education (PACE), Healthcare Economics and Reimbursement, Research and Development, Marketing, Quality Assurance, Business Development, Licensing, Portfolio Management, and Corporate Legal in Grants and Compliance.• Led the development and generation of Asia's Evidence-Based Medicine(EBM).Covidien is a $10 billion global healthcare products leader dedicated to innovation and long-term growth. Covidien creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence.Over the years, we've pioneered a number of medical advances, including pulse oximetry, electrosurgery, surgical stapling, laparoscopic instrumentation and embolization devices. This extensive product line, spanning medical devices and medical supplies, enables us to serve healthcare needs in hospitals, long-term care and alternate care facilities, doctors’ offices and in the home.Implemented the Global Medical Affairs strategies and tactics for Surgical Devices.Provided operational support and strategic direction to Clinical Operations, Procedural And Clinical Education (PACE) and Healthcare Economics & Reimbursement, Research & Development, Marketing, Quality Assurance, Business Development & Licensing, Portfolio Management and Corporate Legal in Grants and Compliance. Spearheaded the development and generation of Asia's Evidence Based Medicine(EBM). -
Regional Medical DirectorSchering-Plough 2006 - Dec 2010Rahway, New Jersey, UsSchering-Plough is an innovation-driven, science-centered global health care company with operations in more than 140 countries, net sales in excess of $18.5billion and over 51,000 employees.Appointed to set up and lead the global medical affairs strategy and activities for Asia Pacific (Australia through to China/India), partnering with Global Clinical Operations (GCO) in overseeing clinical trials as well as with Regional Pharmacovigilence and Regional Regulatory to create a senior regional medical matrixed team. Directed and led the strategy which managed the coming together of all Medical Directors across the Asia Pacific (14 countries), introducing a consolidated approach to achieving alignment in global goals and vision.Developed regional clinical research programs and clinical trial strategies, Managing compliance with health and ethical committees and representing the company on cross-company boards and industry associations.Set up and organised Advisory Boards for therapeutic areas, ensuring compliance with country regulations.Formed part of the Global Brand Medical Directors team in the development of a global MA strategy which will achieve Schering-Plough's global objectives and vision.Championed best practice and providing consultation to medical and scientific advice to business units, Regional Operating President and General Managers as required.Identified licensing opportunities together with the business development team.Led the training of local Clinical Operations staff in medical/scientific matters.The amalgamation of Asia Pacific Medical Affairs has resulted in Schering-Plough being able to quickly expand into newly developed areas with revenues growing from S$370m to S$900m and a business model that promotes the business through Key Opinion Leaders and Medical Brand Champions. -
Chief Executive OfficerGleneagles Hospital, Singapore Jan 2000 - Jan 2006Gleneagles Hospital houses 380 beds, tertiary acute care and multi-specialty, providing high quality healthcare services to local, expatriate and foreign patients from all over the world. The Hospital is also a regional centre for medical referrals and houses 200 specialists in its medical centre. Gleneagles' key strengths include its patient focus, user-friendly services, quality care, specialists' expertise and proven technology. Gleneagles was accredited with the Joint Commission International (JCI), the world leader in improving the quality of healthcare, in 2006. Provided leadership and direction across a team of 800 staff with over S$100million in revenues, meeting the needs of the Board and the Board's owners; Parkway Group Healthcare. Successfully addressed critical issues relating to low staff morale prior to appointment and stabilised hospital operations to initiate a full turn-around strategy. -
Senior Regional DirectorCovance Inc. ( A Laboratory Corp. Of America Holdings) Jan 1995 - Jan 2000Princeton, New Jersey, UsCovance is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.5 billion, global operations in more than 20 countries, and more than 8,900 employees. Successfully directed, started-up and ran a new Regional Asian Hub for Drug Development Services company (Covance) in Asia with the regional centre in Singapore. Pioneered the establishment and ongoing development of Asia Pacific operations, setting up country operations across Thailand; Led Business Development strategies, meeting with and pitching to a broad range of clients including Japan. Directed and managed the setting up of all business operations including hiring of employees, setting up of the finance and administration functions. Managed government and legislative requirements and played a chief role in the pioneering and drafting of Singapore's GCP guidelines under the helm of Ministry of Health. Led clinical research management, monitoring and central laboratory services to complete clinical research in phases II, III and IV. Initiated the setting up of Asia's first privately owned Clinical Research Centre (i.e. Gleneagles CRC) to tap the specialists as investigators in the various therapeutic areas and their pool of patients. Spearheaded the collaboration of 5 leading Asia Pacific Cancer Research Groups in an effort to address the unmet needs of research into 'Asian Cancers'. -
Regional Medical Advisor, AsiaGlaxo Wellcome Jan 1993 - Jan 1995Spearheaded the Clinical phase 3 and 4 studies for Asia in Hepatitis B. Developed KOL thought leader management.
-
Pioneer PractitionerRaffles Medical Group Jan 1992 - Jan 1993Singapore, SgStarted up a private clinic to cater to corporate clients. -
Senior Medical OfficerMinistry Of Health (Singapore) Jan 1986 - Jan 1991Singapore, Singapore, SgSpecialty patient care
Dr Timothy Low ,Pbm,Author,Ceo,Board Director Skills
Clinical Trials
Medical Devices
Pharmaceutical Industry
Healthcare
Clinical Research
Clinical Development
Strategy
Regulatory Affairs
Healthcare Management
Medical Affairs
Strategic Planning
Medicine
Hospitals
Pharmacovigilance
Product Launch
Gcp
Oncology
Biotechnology
Drug Development
Cro
Therapeutic Areas
Cardiology
Market Development
Health Economics
Pharmaceutical Sales
Surgery
Hospital Administration
Sales Effectiveness
Thought Leader Management
Ctms
Infectious Diseases
Biopharmaceuticals
Market Access
Pharmaceutics
Clinical Operations
Medical Communications
Diabetes
Medical Writing
Regulatory Submissions
Sop
Neurology
Lifesciences
Gastroenterology
Urology
Hospital Sales
Endocrinology
Pharmaceutical Medical Affairs
Dermatology
Hematology
Vaccines
Dr Timothy Low ,Pbm,Author,Ceo,Board Director Education Details
-
National University Of SingaporePhysician -
Catholic High School (Singapore)Science
Frequently Asked Questions about Dr Timothy Low ,Pbm,Author,Ceo,Board Director
What company does Dr Timothy Low ,Pbm,Author,Ceo,Board Director work for?
Dr Timothy Low ,Pbm,Author,Ceo,Board Director works for Farrer Park Hospital
What is Dr Timothy Low ,Pbm,Author,Ceo,Board Director's role at the current company?
Dr Timothy Low ,Pbm,Author,Ceo,Board Director's current role is CEO and Board Director.
What is Dr Timothy Low ,Pbm,Author,Ceo,Board Director's email address?
Dr Timothy Low ,Pbm,Author,Ceo,Board Director's email address is lo****@****.com.sg
What schools did Dr Timothy Low ,Pbm,Author,Ceo,Board Director attend?
Dr Timothy Low ,Pbm,Author,Ceo,Board Director attended National University Of Singapore, Catholic High School (Singapore).
What are some of Dr Timothy Low ,Pbm,Author,Ceo,Board Director's interests?
Dr Timothy Low ,Pbm,Author,Ceo,Board Director has interest in Social Services, Education, Scuba Diving, Basketball, Reading, Science And Technology, Music, Squash, Disaster And Humanitarian Relief, Golf.
What skills is Dr Timothy Low ,Pbm,Author,Ceo,Board Director known for?
Dr Timothy Low ,Pbm,Author,Ceo,Board Director has skills like Clinical Trials, Medical Devices, Pharmaceutical Industry, Healthcare, Clinical Research, Clinical Development, Strategy, Regulatory Affairs, Healthcare Management, Medical Affairs, Strategic Planning, Medicine.
Who are Dr Timothy Low ,Pbm,Author,Ceo,Board Director's colleagues?
Dr Timothy Low ,Pbm,Author,Ceo,Board Director's colleagues are Rhea Encio, Yen Ping Teoh, Evelyn Camacho, Aevorie Joan Zumel Lota, Danilo Jr Dalida, Yang Ling, Kanayan Parrbathi.
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial